NAV
14.05(0.41%)Fund Size (CR)
₹174.14Expense Ratio
2.38Scheme Type
Active FundValue Research
Min. investment
₹500Minimum Additional Investment
₹500Minimum SIP Investment
₹100Minimum Withdrawal
₹500Exit Load
1% of applicable Net Asset Value - If the amount sought to be redeemed or switch out is invested for a period of up to 3 months from the date of allotment Nil - If the amount, sought to be redeemed or switch out is invested for a period of more than 3 months from the date of allotment1%Return Since Launch
20.24%
- 3M
- 6M
- 1Y
- 3Y
- All
Basic Details
Scheme Manager
Ramesh Mantri
Bench Mark
BSE Healthcare TRI
Type
OPEN
Lumpsum Returns
| Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 26 November 2025 | 9899.58 | -1.00% | - | -0.92% | 495/940 |
| 1 Month | 3 November 2025 | 9811.45 | -1.89% | - | -0.97% | 634/936 |
| 3 Month | 3 September 2025 | 10023.63 | 0.24% | - | 2.40% | 682/916 |
| 6 Month | 3 June 2025 | 10805.93 | 8.06% | - | 5.11% | 152/872 |
| 1 Year | 3 December 2024 | 10448.61 | 4.49% | 4.49% | 1.82% | 230/776 |
| 3 Year | - | - | - | - | - | -/- |
| 5 Year | - | - | - | - | - | -/- |
| Since Inception | 6 February 2024 | 13998.00 | 39.98% | 20.24% | 12.10% | 144/948 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
| Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 1 January 2025 | 1,20,000 | 126891.53 | 5.74% | 5.74% |
| 3 Year | - | - | - | - | - |
| 5 Year | - | - | - | - | - |
| 10 Year | - | - | - | - | - |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
- Investment type
- Scheme based
- SIP
- Lumpsum
Monthly Investment (₹)
Expected Returns Rate (%)
Time Period (in Years)
Invested Amount
₹25,000
Estimated Returns
₹19,059
76%
Returns
Future value of your investment
₹44,059
Risk Ratios
4.86%
Standard Deviation
0.82%
Beta
0.91%
Sharpe Ratio
0.02%
Treynor's Ratio
12.22%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
| Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
|---|---|---|---|---|---|
| Sun Pharma.Inds. | 7.82% | 221923 | 37.52 | Equity | Pharmaceuticals |
| Divi's Lab. | 6.87% | 48915 | 32.96 | Equity | Pharmaceuticals |
| J B Chemicals & | 6.48% | 185047 | 31.13 | Equity | Pharmaceuticals |
| Fortis Health. | 6.32% | 296656 | 30.35 | Equity | Healthcare |
| Laurus Labs | 4.68% | 235550 | 22.46 | Equity | Pharmaceuticals |
| Cipla | 4.20% | 134161 | 20.14 | Equity | Pharmaceuticals |
| Neuland Labs. | 3.82% | 11144 | 18.36 | Equity | Pharmaceuticals |
| Lupin | 3.73% | 91239 | 17.91 | Equity | Pharmaceuticals |
| Sai Life | 2.94% | 153913 | 14.13 | Equity | Pharmaceuticals |
| Krishna Institu. | 2.73% | 181624 | 13.10 | Equity | Healthcare |
Peer Comparison
| Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Direct (G) | 375.16 | 0.72% | 14.81% | 51.57% | 49.56% | 36.23% | |
| Nippon India Taiwan Equity Fund - Direct (IDCW) | 375.16 | 0.72% | 14.81% | 51.57% | 49.56% | 36.23% | |
| Aditya Birla SL International Equity Fund - Direct (G) | 191.83 | 1.60% | 6.61% | 16.88% | 30.83% | 15.89% | |
| Aditya Birla SL International Equity Fund - Direct (IDCW) | 191.83 | 1.60% | 6.61% | 16.88% | 30.83% | 15.89% | |
| Franklin Asian Equity Fund - Direct (G) | 247.79 | -2.03% | 9.44% | 19.76% | 22.77% | 12.50% |
List of Schemes under WhiteOak Capital Mutual Fund
News
WhiteOak Capital Mutual Fund Announces Resignation of Key Personnel
WhiteOak Capital Mutual Fund has announced that, Mr. Vaiibhavv Chugh will cease to be the Head ' Sales of WhiteOak Capital Asset Management Limited w.e.f. the close of business hours of September 30, 2025.Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
16 January 2024
Total AUM (Cr)
₹480.08
WhiteOak Capital Pharma and Healthcare Fund-Reg (G) is an Sectoral / Thematic-oriented fund from the renowned AMC, WhiteOak Capital Mutual Fund. Launched in 16 January 2024, this fund is managed by Ramesh Mantri. With assets under management (AUM) worth ₹480.08 (Cr), as of 4 December 2025, WhiteOak Capital Pharma and Healthcare Fund-Reg (G) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 20.24% since its launch.
The current NAV of WhiteOak Capital Pharma and Healthcare Fund-Reg (G) is ₹14.06, as on 4 December 2025. The fund's benchmark index is BSE Healthcare TRI. You can invest in WhiteOak Capital Pharma and Healthcare Fund-Reg (G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹100 while the minimum lumpsum investment is ₹500.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
The fund has generated undefined% and undefined% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 90.88% in Equity, 9.17% in Debt and -0.05% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 58.06% in Pharmaceuticals & Biotech, 26.17% in Healthcare Services, 11.91% in Debt, 1.91% in Industrial Products, 1.25% in Healthcare Equipment & Su